NCT04563260View on ClinicalTrials.gov

Effect of Palonosetron on Remifentanil for Preventing Emergence Cough in Female

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

March 19, 2021

Study Completion Date

March 19, 2021

Conditions
Gallbladder Diseases
Interventions
DRUG

Normal saline injection

Normal saline 2 mL, intravenous injection

DRUG

Palonosetron Injection [Aloxi]

Palonosetron 1.5 mL (0.075 mg) + Normal saline 0.5 mL, intravenous injection

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT04563260 - Effect of Palonosetron on Remifentanil for Preventing Emergence Cough in Female | Biotech Hunter | Biotech Hunter